Bethesda Diabetes Research Center B.V.

Gestational diabetes mellitus

Bethesda Diabetes Research Center B.V. focuses on clinical research in gestational diabetes mellitus, with attention to maternal glucose regulation, insulin resistance, and pregnancy-related metabolic care. The funded study examines treatment strategies for women diagnosed with GDM and tracks outcomes for both mother and child across pregnancy and the postnatal period.

  • Maternal glycaemic control
  • Insulin resistance
  • Pregnancy outcomes
  • Neonatal health

The research activity is centred on endocrine and metabolic aspects of diabetes in pregnancy, with a clinical interest in how treatment choices may influence short- and long-term outcomes after delivery.

Maternal-fetal medicine

The sponsor’s research landscape includes maternal-fetal medicine, especially conditions where pregnancy, placental metabolism, and fetal development are affected by maternal hyperglycaemia. This area reflects an interest in managing risks that extend from antenatal care into early childhood and later life.

  • Pregnancy care
  • Fetal growth
  • Perinatal outcomes
  • Postpartum follow-up

Clinical interest extends beyond delivery, with outcomes assessed in the weeks after birth and during longer-term follow-up of maternal and child health.

Metabolic disease management

Research supported by the sponsor is also aligned with metabolic disease management, particularly the use of treatment approaches that target abnormal glucose handling in pregnancy. The focus is on therapeutic control of diabetes-related metabolic disturbance and its impact on clinically relevant endpoints.

  • Glucose metabolism
  • Diabetes in pregnancy
  • Therapeutic response
  • Long-term metabolic outcomes

This includes interest in how interventions may shape maternal metabolic status after childbirth and influence later health trajectories in the child.

Longitudinal outcome assessment

The sponsor funds work with a strong longitudinal outcome assessment component, tracking clinical effects from diagnosis through pregnancy and into extended follow-up. This makes postpartum health and extended child development relevant areas of interest within its research portfolio.

  • Postpartum maternal outcomes
  • Infant health
  • Child development
  • Extended follow-up

The funded research places emphasis on endpoints that capture both immediate clinical effects and later consequences for mother and child.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Metformin in Pregnant Women with Gestational Diabetes

    Not recruiting

    3 1 1 1
    Investigated drugs:
    The Netherlands